Scripps VIVO scripps research logo

  • Index
  • Log in
  • Home
  • People
  • Organizations
  • Research
  • Events
Search form

Monoclonal-antibodies against complement-3 neoantigens for detection of immune-complexes and complement activation - relationship between immune-complex levels, state of c-3, and numbers of receptors for c3b

Academic Article
uri icon
  • Overview
  • Identity
  • Additional Document Info
  • View All
scroll to property group menus

Overview

authors

  • Aguado, M. T.
  • Lambris, J. D.
  • Tsokos, G. C.
  • Burger, R.
  • Bittersuermann, D.
  • Tamerius, J. D.
  • Dixon, F. J.
  • Theofilopoulos, Argyrios

publication date

  • 1985

journal

  • Journal of Clinical Investigation  Journal

abstract

  • C3-bearing immune complexes and C3 activation products were detected by using two monoclonal antibodies, one specific for a neoantigenic determinant on C3c and the other for C3d. To quantitate immune complexes, the anti-C3c or anti-C3d antibodies were fixed to microtiter plates and reacted with test plasma. The binding of C3-bearing immune complexes in this plasma was then measured with radioisotope- or enzyme-labeled anti-human IgG. To test for C3 breakdown products, solid-phase monoclonal antibody to the C3d neoantigen was reacted with EDTA-plasma samples, and fixed iC3b or C3d was measured with a polyclonal anti-C3 antibody. Patients with autoimmune diseases, such as systemic lupus erythematosus, rheumatoid arthritis, and Sjogren's syndrome, and paracoccidioidomycosis were found to contain immune complexes bearing C3b/iC3b or C3d. In most conditions, there were more C3d-containing immune complexes than C3b/iC3b. Although CR1 (C3b receptors) rapidly converted immune complex-bound iC3b to C3dg/C3d and lupus patients had reduced CR1, no correlation between the state of C3 on circulating immune complexes or levels of immune complexes and CR1 numbers was seen. However, levels of C3-fixing ICs correlated with levels of C3 activation products. This assay system with monoclonal antibodies to neoantigens expressed on activated, but not native, C3 provides sensitive and specific means for detecting and classifying C3-fixing immune complexes and for assessing C3 activation.

subject areas

  • Antibodies, Monoclonal
  • Antibody Specificity
  • Antigen-Antibody Complex
  • Arthritis, Rheumatoid
  • Autoimmune Diseases
  • Complement Activation
  • Complement C3
  • Complement C3c
  • Complement C3d
  • Humans
  • Lupus Erythematosus, Systemic
  • Paracoccidioidomycosis
  • Receptors, Complement
  • Receptors, Complement 3b
  • Sjogren's Syndrome
scroll to property group menus

Identity

International Standard Serial Number (ISSN)

  • 0021-9738

Digital Object Identifier (DOI)

  • 10.1172/jci112119

PubMed ID

  • 2932466
scroll to property group menus

Additional Document Info

start page

  • 1418

end page

  • 1426

volume

  • 76

issue

  • 4

©2019 The Scripps Research Institute | Terms of Use | Powered by VIVO

  • About
  • Contact Us
  • Support